6/22/20

American Association for Cancer Research (AACR) Virtual Annual Meeting II, June 22-24, 2020

• Poster Presentation: A STAT3-selective targeted protein degrader decreases the immune-suppressive tumor microenvironment and drives anti-tumor activity in preclinical models
• Poster Presentation: IRAKIMiDs: Protein degraders targeting both IRAK4 and IMiD substrates show combinatorial effects leading to broad activity with durable regressions in MYD88 mutant lymphoma xenografts in vivo